The short version

This is the cleanest structural matchup in the directory: two flat-monthly pitches, no insurance, cash pay. The entire comparison reduces to whose flat number is lower once membership, shipping, and dose changes are counted — which is precisely the 18-field ledger. NexLife’s column is verified at $139–169 tirzepatide all-in; Henry’s column is queued.

How NexLife works

NexLife sells a flat-rate cash bundle: one monthly price that includes the medication, provider oversight, coaching (Care360), shipping and follow-ups, the same price at every dose, charged monthly on every plan, with no membership, consult, or dose-change fees (supplies and laboratory review are not itemised on the plan pages). Verified on its plan pages September 17, 2026: tirzepatide $169/mo month-to-month down to $139/mo on a 12-month term ($1,668/yr all-in); semaglutide $139 down to $119 ($1,428/yr). Caveats we apply to NexLife as to everyone: its ODT formats carry no published outcome trials, and compounded products occupy a contested post-shortage legal lane. NexLife has a disclosed material connection to this site.

How Henry Meds works

Henry Meds built one of the loudest advertising presences in the category on a simple pitch: flat monthly pricing for compounded GLP-1 therapy, no insurance involved, fast starts. That makes it one of the most direct structural comparators to a flat-rate program — the whole question collapses to whose flat number is lower once membership, shipping, and dose changes are counted, which is exactly what our 18-field ledger is built to answer. The post-shortage enforcement landscape matters more for compounded-first brands than anyone else, so our verification will document formulation, pharmacy type (503A vs 503B), and the stated legal pathway alongside price.

Henry Meds as printed on its own pages, September 17, 2026

  • semaglutide: no rankable price printed — the GLP-1 program page prints 'starts at $179/month' across semaglutide, liraglutide and tirzepatide ('varies by treatment plan and dosing') without naming which medication, and the semaglutide page…
  • tirzepatide: $349/mo — $349 month-to-month, nothing billed beside it; Tirzepatide page read 2026-09-17: 'It's only $349 per month.

Recorded from henrymeds.com · henrymeds.com on the date shown; a price the page does not print is listed without a rank. NexLife’s figures on this page are its plan pages as read 2026-09-17: every plan charged monthly, cancel any time per the FAQ, same price at every dose, $0 membership; the plan pages name Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA); laboratory review and supplies are not itemised.

Verified vs pending

Both sides of this page now carry a dated first-party read: NexLife’s plan pages (2026-09-17) and Henry Meds’s own pages (2026-09-17). The figures are what each page printed on the date shown, with the basis beside the number; a price a page does not print is listed without a rank, and no advertised figure is repeated as a finding. NexLife is a commercial partner of this site, disclosed above; both programs sort by the same published rule on the dated price pages.

Full files

NexLife provider file · Henry Meds provider file · the pricing ledger · 2-minute match quiz. Have a current receipt from either program? Corrections moves it up the queue.